Amprius Technologies (NYSE:AMPX) Trading 13.6% Higher – Should You Buy?

Shares of Amprius Technologies, Inc. (NYSE:AMPX) shot up 13.6% during mid-day trading on Thursday . The stock traded as high as $13.78 and last traded at $13.61. 18,143,835 shares were traded during mid-day trading, an increase of 120% from the average session volume of 8,245,461 shares. The stock had previously closed at $11.98.

Amprius Technologies News Summary

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Needham initiated coverage with a Buy and a $20 price target (roughly +61% upside from current levels), a bullish analyst catalyst that likely drew buyer interest and helped fuel recent gains. Needham initiates coverage of Amprius
• Positive Sentiment: MarketBeat highlighted Amprius’ expanding production capacity and new South Korean manufacturing partners, noting the company is ahead of plan and positioning for an improved path to profitability ahead of FY2025 Q4 results (late March) — a concrete operational improvement that supports longer‑term upside. 5 Stocks to Buy in February: Last Year’s Winners Aren’t Done Yet (AMPX)
• Positive Sentiment: Unusual options activity: a large purchase of call options (22,391 contracts) suggests elevated bullish/speculative interest and short‑term upside betting by traders — this can amplify intraday moves and volatility.
• Neutral Sentiment: Several outlets ran takeaways asking whether recent multi‑month gains make AMPX “too late” to buy and examining valuation after a big run; these pieces increase retail attention but don’t settle fundamentals one way or the other. Is It Too Late To Consider Buying Amprius Technologies (AMPX)
• Negative Sentiment: Zacks noted a recent sharp intraday gain but flagged that the trend in earnings‑estimate revisions does not support sustained upside — a warning that analysts’ expectations may not be accelerating enough to justify the rally. Amprius (AMPX) Moves 13.4% Higher: Will This Strength Last?
• Negative Sentiment: Fundamental risk: Amprius still shows negative net margin and negative ROE and trades with a high beta — meaning the stock is sensitive to sentiment swings and could face profit‑taking or re‑rating if upcoming earnings fail to show clear progress toward profitability.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Cantor Fitzgerald raised their price objective on Amprius Technologies from $12.00 to $16.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Northland Securities set a $20.00 price target on Amprius Technologies in a report on Tuesday, October 7th. Needham & Company LLC initiated coverage on shares of Amprius Technologies in a research report on Thursday. They issued a “buy” rating and a $20.00 price target on the stock. Oppenheimer reaffirmed an “outperform” rating and set a $17.00 price objective on shares of Amprius Technologies in a report on Tuesday, December 23rd. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. Seven research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $16.57.

Amprius Technologies Price Performance

The firm has a market cap of $1.62 billion, a P/E ratio of -47.77 and a beta of 3.04. The stock’s 50 day moving average is $10.27 and its two-hundred day moving average is $10.02.

Amprius Technologies (NYSE:AMPX) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03. Amprius Technologies had a negative return on equity of 38.85% and a negative net margin of 53.16%.The company had revenue of $21.43 million for the quarter, compared to the consensus estimate of $16.45 million. As a group, research analysts forecast that Amprius Technologies, Inc. will post -0.45 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Kang Sun sold 43,185 shares of the business’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $11.03, for a total value of $476,330.55. Following the sale, the director owned 1,403,651 shares in the company, valued at approximately $15,482,270.53. The trade was a 2.98% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CTO Constantin Ionel Stefan sold 39,690 shares of the company’s stock in a transaction dated Wednesday, January 28th. The stock was sold at an average price of $12.00, for a total transaction of $476,280.00. Following the completion of the sale, the chief technology officer directly owned 748,696 shares in the company, valued at approximately $8,984,352. The trade was a 5.03% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 3,399,331 shares of company stock worth $37,048,615 over the last quarter. Company insiders own 12.90% of the company’s stock.

Hedge Funds Weigh In On Amprius Technologies

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Stephens Investment Management Group LLC bought a new stake in Amprius Technologies during the 3rd quarter worth approximately $11,392,000. Bessemer Group Inc. acquired a new position in Amprius Technologies in the second quarter worth $174,000. Baird Financial Group Inc. grew its holdings in shares of Amprius Technologies by 99.9% during the second quarter. Baird Financial Group Inc. now owns 1,000,711 shares of the company’s stock worth $4,213,000 after purchasing an additional 500,212 shares during the last quarter. Calamos Advisors LLC bought a new stake in shares of Amprius Technologies during the third quarter worth $1,799,000. Finally, Huntleigh Advisors Inc. acquired a new stake in shares of Amprius Technologies in the second quarter valued at $614,000. 5.04% of the stock is currently owned by institutional investors and hedge funds.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.